Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
5.50
0.00 (0.00%)
At close: Dec 5, 2025

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 2.10B NGN in the quarter ending September 30, 2025, with 46.06% growth. This brings the company's revenue in the last twelve months to 6.40B, up 68.75% year-over-year. In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B with 102.98% growth.

Revenue (ttm)
6.40B
Revenue Growth
+68.75%
P/S Ratio
3.67
Revenue / Employee
36.57M
Employees
196
Market Cap
23.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.49B2.28B102.98%
Dec 31, 20232.21B-709.73M-24.31%
Dec 31, 20222.92B216.47M8.01%
Sep 30, 20222.70B-343.81M-11.28%
Sep 30, 20213.05B207.54M7.31%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BUA Foods 1,877.86B
Dangote Cement 4,174.73B
MTN Nigeria Communications 4,723.08B
BUA Cement 1,151.80B
Aradel Holdings 742.38B
Geregu Power 156.01B
Guaranty Trust Holding Company 1,421.24B
Zenith Bank 2,203.80B
Revenue Rankings